SCHEMBL6173796

SCHEMBL6173796

CC(C)Nc1cc(C(C)C2NC(=O)N(c3ccc(SC(F)(F)F)cc3)C2=O)ccn1

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 18/20 0.52
PDE2A O00408 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6176344 0.88 IGF1R (0.55) IGF1RPDE2A
SCHEMBL6174748 0.87 IGF1R (0.43) IGF1RPDE2A
SCHEMBL6177806 0.87 IGF1R (0.43) IGF1RPDE2A
SCHEMBL6174986 0.87 IGF1R (0.42) IGF1RPDE2A
SCHEMBL6174049 0.86 IGF1R (0.46) IGF1R
SCHEMBL6175915 0.85 IGF1R (0.42) IGF1RPDE2A
SCHEMBL6172754 0.84 IGF1R (0.41) IGF1RPDE2A
SCHEMBL6174760 0.84 IGF1R (0.41) IGF1RPDE2A
SCHEMBL6173932 0.84 IGF1R (0.40) IGF1R
SCHEMBL6175275 0.84 IGF1R (0.41) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed